Systemic IL-1β and TNF-α Productions of E. coli Lipopolysaccharide-Induced Periodontitis Model on Rats

Alma Linggar Jonarta(1*), Widya Asmara(2), Indwiani Astuti(3), Regina TC Tandelilin(4)

(1) Universitas Gadjah Mada, Yogyakarta, Indonesia
(2) Universitas Gadjah Mada, Yogyakarta, Indonesia
(3) Universitas Gadjah Mada, Yogyakarta, Indonesia
(4) Universitas Gadjah Mada, Yogyakarta, Indonesia
(*) Corresponding Author


Periodontal disease, a common inflammatory oral disease involved periodontal tissues, has been linked with the evidence of some systemic disorders. Recently, periodontal disease has been suspected as a trigger of systemic disorders. Penetration of bacterial products, such as lipopolysaccharide (LPS) may reach into deeper periodontal tissues. Therefore there may affect systemic blood and cytokines production. Interleukin-1β (IL-1β) and Tumour Nuclear Factor-α (TNF-α) are known as pro-inflammatory cytokines. The production of systemic IL-1β and TNF-α of E. coli lipopolysaccharide-induced periodontitis model on rats was investigated in this research. Fifteen male Wistar rats, aged 6-8 weeks used for this study were divided into 3 groups. For group 1 and 2, silk ligature 3/0 were inserted in interdental area between upper right molar 1 and 2. First and second group received solution containing 10μg/ml and 1mg/ml E. coli lipopolysaccharide, respectively, mixed
with 2% carboxymethylcellulose (CMC) diluted in 100μl of phosphate buffer saline (PBS). The solution was topically applied on gingival tissues around the gingival sulcus, a single topical application of solution once
per 2 days for 14 days. Untreated subjects were used as negative control. On day 15, the blood was collected from vena orbitalis, and rats were sacrificed. The blood serum of each group was divided into 2 groups and
cultured for 4 hours with or without 20μl of 100ng/ml of E. coli LPS. ELISA techniques were used to measure the cytokine productions of the supernatant. The data was analysed using Repeated Measure ANOVA. This study showed that there was a significant increase of IL-1β production on low dose of LPS compared to control and high dose of LPS groups (p<0.05). Whereas TNF-α not significantly showed increasing trend. The increasing trend of pro-inflammatory cytokine productions, such as IL-1β and TNF-α, on LPS-induced periodontitis model in this experiment supports the previous studies about the contribution of periodontal disease in the pathogenesis of systemic diseases.


IL-1β, TNF-α , E. coli LPS, rat’s periodontitis model

Full Text:



Wakefield D and Kumar RK. 2000. Inflammation: chronic. in Encyclopedia of Life Sciences.

Baker P. 2000. The role of immune responses in bone loss during periodontal disease. Microbiol. Infec., Vol 2: 1181-1192.

Teng YTA, Nguyen H, Gao X, Kong XX, Gorczynski RM, Singh B, Ellen RP, and Penninger JM. 2000. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone

destruction in periodontal infection. J.Clin. Invest., Vol 106: 2000.

Seydel U, Hawkins L, Schromm AH, Heine H, Scheel O, Koch MHJ, and Brandenburg K. 2003. The generalized endotoxic principle. Eur. J. Immunol (33): 1586-1592.

Page R, Offenbacher S, Schroeder H, Seymour G, and Kornman K. 1997. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol (14): 216-248.

Weibe S, Hafezi M, Sandu H, Sims S, and Dixon S. 1996. Osteoclast activation in inflammatory periodontal diseases. Oral Disease (2): 167-180.

Miyauchi M, Sato S, Kitagawa S, Hiraoka M, Kudo Y, Ogawa I, Zhao M, Takata T. 2001. Cytokine expression in rat molar gingival periodontal tissues after topical application of lipopolysaccharide. Histochem Cell Biol (116): 57-62.

Scannapieco FA. 2005. Systemic effects of periodontal diseases. Dent. Clin. N. Am (49): 533–550.

Munford RS, Andersen JM, and Dietschy JM. 1981. Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes. J. Clin. Invest. (68): 1503-1513.

Day J, Rubin J, Vodovotz Y, Chow CC, Reynolds A, and Clermont G.2006. A reduced mathematical model of the acute infammatory response II. Capturing scenarios of repeated endotoxin administration. Journal of Theoretical Biology (242): 237-256.

Fokkema S, Loos B, Slegte C, and Van Der Velden U. 2002. A type 2 response in lipopolysaccharide (LPS)-stimulated whole blood cell cultures from periodontitis patients. Clin Exp Immunol (127):


Gustafsson A, Ito H, Asman B, and Bergstrom K. 2006. Hyper-reactive mononuclear cells and neutrophils in chronic periodontitis. J. Clin. Periodontol (33): 126-129.

Delaleu N and Bickel M. 2004. Interleukin-1β and interleukin-18: regulation and activity in local inflammation. Periodontol 2000 (35): 42-52.

Cannon J, Tompkins R, Gelfand J, Michie H, Stanford G, van der Meer J, Endres S, Lonnemann G, Corsetti J, Chernow B. 1990. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis (161): 79-84.

Michie HR, Manogue KR, Spriggs DR, Revhaug A, O’Dwyer S, and Dinarello CA. 1988. Detection of circulating tumour necrosis factor after endotoxin administration. N. Engl. J. Med (318): 1481-1486.

Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN, and van Dyke TE.2007. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue

homeostasis in vivo. J. immunol. (179): 7021-7029.

Górska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, and Madalinski JM.2003. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. Clin Periodontol. (30): 1046-1052.

De Queiroz AC, Taba MJ, O’Connell PA, da Nobrega PA, Costa PP, Kawata VKDS, Trevisan GL, Novaes ABJ, Souza SLS, Palioto DB, and Grisi MFDM. 2008. Inflammation markers in healthy and periodontitis patients. A preliminary data screening. Braz. Dent. J. (19): 3-8.

Beeson PB. 1948. Tolerance go bacterial pyrogens. I. Factor influencing its development. J. Exp. Med. (86): 29-38.

Tapping RI, Akashi S, Godowski KMJ, and Tobias PS. 2000. Toll-Like receptor 4, but not Toll-Like Receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol (165): 5780-5787.

Faure E, Thomas L, Xu H, Edvedev AE, Equils O, and Arditi M. 2001. Bacterial lipopolysaccharide and IFN-g induce Toll-Like Receptor 2 and Toll-Like Receptor 4 expression in human endothelial cells: Role of NF-kB activation. J Immunol (166): 2018-2024.

Fitting C, Dhawan S, and Cavaillon JM. 2004. Compartmentalization of tolerance to endotoxin. J. Infect. Dis (189): 1295-1303.


Article Metrics

Abstract views : 666 | views : 635


  • There are currently no refbacks.





website statistics


View My Stats